Examining the Latency Effect in Patients With Chronic Pain Treated With Spinal Cord Stimulation: A Follow-Up Study to the Open, Interventional, Investigator-Initiated, International, Multicenter EChO Study.
Researchers
Kaare Meier, Cecile C de Vos, Michel Prud'homme, Martine Bordeleau, Bart Billet, Thomas Ruland, Morten Rune Blichfeldt-Eckhardt, Matthias Winkelmüller, Helga Angela Gulisano, Kliment Gatzinsky, Anne Lene Knudsen, Jens Christian Hedemann Sørensen, Sylvine Carrondo Cottin, Ioanna Milidou
Abstract
Our previous prospective, international, multicenter study, the Examining the Duration of Carryover Effect in Patients With Chronic Pain Treated With Spinal Cord Stimulation (EChO Study), confirmed the common clinical observation that when spinal cord stimulation (SCS) treatment is deactivated, there is a variable interval before the patient perceives the return of pain, a phenomenon often termed the carryover effect. When SCS treatment is resumed, there is also a time interval before the treatment effect is restored; this is known as latency. This follow-up study to the EChO study aimed to investigate and quantify the latency effect and assess correlations with the carryover effect and with clinical and treatment parameters. Eligible patients with a beneficial effect of their SCS treatment were instructed to deactivate their SCS device in a home setting, reactivate it when their pain returned, and record the time when the pain-relieving treatment effect was reinstated. The correlation between carryover and latency was investigated using linear regression. The association between central clinical parameters (age, sex, indication for SCS, SCS treatment details, and pain score) and latency was analyzed using nonparametric tests (Mann-Whitney/Kruskal-Wallis) for categorical data and linear regression for continuous data. A total of 151 patients were included in the analysis. A median latency of 3.5 hours was found (interquartile range 1-12.2). Only back pain as the indication (n = 19) for SCS therapy and 10 kHz stimulation (n = 13) were associated with longer latency. This study confirms the existence of the latency effect and demonstrates a lower median and a lower degree of interindividual variation than that of the carryover effect. The analyses suggest that, rather than being a mirror aspect of the carryover effect, the latency effect could likely be considered a different physiological phenomenon. The results emphasize the importance of accounting for the latency effect in clinical practice and in designing clinical trials. The Clinicaltrials.gov registration number for the study is NCT03386058.Source: PubMed (PMID: 43043337)View Original on PubMed